D.C. Marketplace encourages labs to remove race from kidney function test to advance equity
The Health Insurance Marketplace for the District of Columbia is encouraging labs to remove race as a variable in the estimated glomerular filtration rate (eGFR) formula commonly used to measure kidney function, as recommended by the National Kidney Foundation and American Society of Nephrology to support health equity. The use of race in the equation for eGFR can exacerbate disparities in health outcomes. The D.C. marketplace, known as DC Health Link, covers 100,000 enrollees and 5,300 employers in all 50 states.
Related News Articles
Headline
The AHA Aug. 7 launched a new webpage, Reducing Disparities in Health Outcomes, featuring new and familiar resources for members and their communities. As part…
Headline
A study published March 31 by the National Institutes of Health found that adults living in rural areas have worse cardiovascular health than those in urban…
Headline
The AHA’s newly released infographic highlights the importance of leveraging community collaborations to address health disparities for all populations.
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…
Headline
The AHA’s Institute for Diversity and Health Equity will host its next Health Equity Innovation Summit in Washington, D.C., on Nov. 12 from 9:30 a.m. to 3:30 p…
Headline
The AHA's Institute for Diversity and Health Equity has extended until Nov. 7 the deadline to apply for the 2025 Carolyn Boone Lewis Equity of Care Awards,…